- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Survivin: a unique target for tumor therapy ; volume:16 ; number:1 ; day:23 ; month:6 ; year:2016 ; pages:1-14 ; date:12.2016
Cancer cell international ; 16, Heft 1 (23.6.2016), 1-14, 12.2016
- Creator
-
Garg, Himani
- Contributor
-
Suri, Prerna
Gupta, Jagdish C.
Talwar, G. P.
Dubey, Shweta
SpringerLink (Online service)
- DOI
-
10.1186/s12935-016-0326-1
- URN
-
urn:nbn:de:1111-2016062421500
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Garg, Himani
- Suri, Prerna
- Gupta, Jagdish C.
- Talwar, G. P.
- Dubey, Shweta
- SpringerLink (Online service)
Other Objects (12)
Novel strategies to target the survivin pathway in cancer – interference with nuclear export prevents the tumor promoting activites of survivin : meeting abstract
Expression von Survivin in Zellen urologischer Tumoren
Die prognostische Bedeutung von Survivin bei gastroenteropankreatischen neuroendokrinen Tumoren
Endothelin receptors as novel targets in tumor therapy
Tumor-Associated Macrophages as Target for Antitumor Therapy
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
Gastrointestinal stromal tumor (GIST) : from pathology to molecular target therapy
Peripheral medulloepithelioma: a rare tumor with a potential target therapy
Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
Novel strategies to target the survivin pathway in cancer – interference with nuclear export prevents the tumor promoting activites of survivin : meeting abstract
Expression von Survivin in Zellen urologischer Tumoren
Die prognostische Bedeutung von Survivin bei gastroenteropankreatischen neuroendokrinen Tumoren
Endothelin receptors as novel targets in tumor therapy
Tumor-Associated Macrophages as Target for Antitumor Therapy
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
Gastrointestinal stromal tumor (GIST) : from pathology to molecular target therapy
Peripheral medulloepithelioma: a rare tumor with a potential target therapy
Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
Novel strategies to target the survivin pathway in cancer – interference with nuclear export prevents the tumor promoting activites of survivin : meeting abstract
Expression von Survivin in Zellen urologischer Tumoren
Die prognostische Bedeutung von Survivin bei gastroenteropankreatischen neuroendokrinen Tumoren
Endothelin receptors as novel targets in tumor therapy
Tumor-Associated Macrophages as Target for Antitumor Therapy
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
Gastrointestinal stromal tumor (GIST) : from pathology to molecular target therapy
Peripheral medulloepithelioma: a rare tumor with a potential target therapy